ask="0.7296"
ask_size="1000"
average_daily_volume="2073470"
bid="0.5787"
bid_size="200"
book_value="0.1800"
change="-0.0345"
change_from_200_day_moving_average="-1.4292"
change_from_50_day_moving_average="0.0529"
change_from_52_week_high="-4.2233"
change_From_52_week_low="0.1667"
change_in_percent="-4.8510%"
close="0.6767"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.4440"
ebitda="-49.68M"
eps_estimate_current_year="-1.5900"
eps_estimate_next_quarter="-0.3300"
eps_estimate_next_year="-1.2900"
ex_dividend_date="N/A"
float_shares="36794000"
high="0.7199"
high_52_weeks="4.9000"
last_trade_date="2/16/2017"
last_trade_price="0.6767"
last_trade_size="8436"
last_trade_time="4:00pm"
low="0.6600"
low_52_weeks="0.5100"
market_capitalization="28.39M"
moving_average_200_day="2.1059"
moving_average_50_day="0.6238"
name="Anthera Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.8500"
open="0.7150"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-67.8665%"
percent_change_from_50_day_moving_average="+8.4761%"
percent_change_from_52_week_high="-86.1898%"
percent_change_from_52_week_low="+32.6863%"
previous_close="0.7112"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.9511"
price_per_sales="14.4636"
revenue="2.06M"
shares_outstanding="41955000"
short_ratio="3.7000"
stock_exchange="NGM"
symbol="ANTH"
volume="1327375"
weeks_range_52="0.5100 - 4.9000"
